As a result of their rigorous work schedules, Driftwood Hospitality employees were allegedly unable to take off duty meal breaks and were not fully relieved of duty for meal periods. Specifically, the lawsuit alleges employees were from time to time interrupted during their off-duty meal breaks to complete tasks for Driftwood Hospitality. Employees were allegedly required to perform work as ordered by Driftwood Hospitality for more than five (5) hours during a shift without receiving an off-duty meal break. Further, the lawsuit alleges Driftwood Hospitality failed to provide employees with a second off-duty meal period each workday in which these employees were required by Driftwood Hospitality to work ten (10) hours of work. The policy of Driftwood Hospitality, allegedly caused employees to remain on-call and on duty during what was supposed to be their off-duty meal periods. Employees therefore allegedly forfeited meal breaks without additional compensation and in accordance with the strict corporate policy and practice of Driftwood Hospitality.
If you would like to know more about the Driftwood Hospitality lawsuit, please contact Attorney Jackland Hom today by calling (619) 255-9047.
Zakay Law Group, APLC, and JCL Law Firm, APC are labor and employment law firms with offices located in California that dedicate their practices to fighting for employees who have been wronged by their employers due to unfair employment practices. Contact one of their attorneys today if you need help with workplace issues regarding wage and hour, wrongful termination, retaliation, discrimination, and harassment.
-THIS IS AN ATTORNEY ADVERTISEMENT (Rules Prof. Conduct, rule 7.2)-
Eleven local support agencies will come together for a community event at the recently opened addiction clinic in Great Falls on Wednesday, August 7, 12 p.m. – 3 p.m.
GREAT FALLS, Mont., July 29, 2024 /PRNewswire-PRWeb/ — Ideal Option, a national leader in outpatient medication-assisted treatment for opioids, methamphetamine, alcohol and polysubstance, is partnering with local agencies to host a Health, Safety & Recovery Resource Fair in Great Falls. The event will be held at their addiction medicine clinic, located at 617 10th Ave S. Mayor Cory Reeves and Recovery Advocate Lea Wetzel will give an opening address.
On Wednesday, August 7, 12 p.m. – 3 p.m., all members of the community are invited to learn more about local resources, meet their staff, explore the clinic and discuss solutions for the escalating opioid crisis in Cascade County. Great Falls EMS will conduct CPR demonstrations and ambulance tours, and there will be a superhero coloring activity for children. Light refreshments will be provided.
Participating organizations include:
Ideal Option
Great Falls EMS
Indian Family Health Clinic
Toby’s House Crisis Nursery
Family Promise of Great Falls
The Sober Life
Great Falls College
City-County Health Department
Opportunities, Inc.
Dynamic Recovery
Little Shell Tribal Health
Frosty of Montana food truck will also be onsite. Individuals can RSVP to the Facebook event here: bit.ly/GF-resource-fair.
For questions about this event, email marketing director Olivia Roe at [email protected].
About Ideal Option
Headquartered in Kennewick, Washington, Ideal Option was founded in 2012 and has since helped more than 82,000 patients through a network of 80+ office-based medication-assisted treatment (MAT) clinics across 9 states. Ideal Option has received The Joint Commission’s Gold Seal of Approval®, demonstrating compliance with its exacting performance standards for safety and quality of patient care. With a mission to serve under-served communities, Ideal Option accepts all forms of insurance including Medicaid and Medicare. Financial assistance and payment plans are also available.
Ideal Option’s team of medical providers carry certifications in Addiction and Emergency Medicine, Internal, and Family Medicine, among other specialties. The company also employs social workers, caseworkers, counselors, and mental health practitioners. This holistic approach helps drive positive outcomes, including family stability, stable housing, improved overall health, and reduced rates of recidivism.
In all the communities it serves, Ideal Option collaborates with existing stakeholders and providers to improve the continuum of care. This approach includes partnerships with emergency rooms and county jail systems, where individuals with substance use disorder often appear, as well as collaborating with numerous support agencies and municipal programs addressing social needs such as housing, mental health, and nutrition support.
The newly integrated codes can then measure HCP awareness and knowledge both before and after a scientific exchange. The comparison of the results can then indicate whether the meeting produced any shift in perspectives based on the sharing of medical information and the related discussion.
These survey tools can be utilized by both HCPs and MSLs, with the data being aggregated by Beacon for various reports and deeper analytics.
“Medical Affairs teams always want to ensure that they are providing educational value to HCPs and their broader life science organizations. This new capability in the Beacon platform now provides a user friendly and practical way to help ascertain this,” said Dapo Tomori, MD, an experienced Medical Affairs executive and physician.
Dave Gulezian, Alucio’s Co-Founder & CEO, added: “The ability to quantify learning effectiveness as a result of a scientific exchange can be a struggle for Medical Affairs and MSL teams. Our customers and users are very excited about how these new Beacon features can help demonstrate the impact of their educational efforts.”
About Alucio:
Alucio is dedicated to the development of innovative software applications specifically for the life sciences industry. Alucio’s flagship product, Beacon, is a modern, cloud-based scientific exchange platform that enhances scientific dialogue and engagement between life science companies and healthcare professionals. For more information, please visit the company’s website at http://www.alucio.io or contact Lisa Amin at [email protected] (925) 788-3533.
A total of 53 randomized control trials that included 4695 patients and 28 anesthetic combinations during GA induction and LMA insertion were included in the NMA. Propofol was used as the only comparator against other anesthetics. The primary outcome analyzed was prolonged apnea, with secondary outcomes of adverse airway events, LMA insertion failure, inadequate depth of anesthesia, and hemodynamic events.
Researchers found an apnea incidence rate of 33.3% (mean time of 3.74 ± 3.56 minutes). When compared against all propofol combinations, other than the propofol and thiopental combination, propofol alone was found to be the least effective at reducing adverse effects; the propofol and dexmedetomidine combination was found to be the most effective for reducing adverse outcomes during LMA insertion.
The research presented in this study appears to be the first of its kind to compare and rank the effectiveness of all anesthetic combinations used for GA induction during LMA insertion, with the propofol and dexmedetomidine combination being the most effective. Goertzen and colleagues conclude, “The NMA method allows for direct and indirect comparisons of multiple treatments when head-to-head comparisons are not always available in the literature. In the studies that met our inclusion criteria, 48 different anesthetics and anesthetic combinations were identified. This study demonstrates that the comparison of different anesthetic combinations with an NMA is feasible and effective.”
Anesthesia Progress is the official publication of the American Dental Society of Anesthesiology (ADSA). The quarterly journal is dedicated to providing a better understanding of the advances being made in the science of pain and anxiety control in dentistry. The journal invites submissions of review articles, reports on clinical techniques, case reports, and conference summaries. To learn more about the ADSA, visit: http://www.adsahome.org/.
Media Contact
Samantha Weinkauf, KnowledgeWorks Global Ltd., 1 785-289-2649, [email protected]
“We are honored to receive this award. Our goal is to help patients regain their confidence with the most advanced and least invasive hair transplantation methods available,” says Dr. Benjamin Stong.
More about Dr. Benjamin Stong: Dr. Benjamin Stong is the owner of Kalos Hair Transplant in Atlanta, Georgia. He graduated from the University of Alabama School of Medicine and completed his internship in general surgery and residency at Emory University’s Department of Otolaryngology. Dr. Stong then pursued a fellowship in facial plastic and reconstructive surgery with Dr. Andrew Jacono, a nationally renowned plastic surgeon in NYC. Throughout his career, Dr. Stong has earned numerous accolades for his expertise and patient care.
Kalos Hair Transplant, located at 371 East Paces Ferry Rd, Suite 850 in Atlanta, Georgia, is dedicated to providing state-of-the-art hair restoration solutions. In addition to NeoGraft, Dr. Stong offers a variety of hair restoration options, including Follicular Unit Transfer and non-surgical treatments. The clinic also specializes in beard and eyebrow hair transplants, as well as forehead reduction procedures.
For more information or to schedule a consultation with Dr. Benjamin Stong, please call (404) 963-0871 or visit http://www.kaloshairtransplant.com.
By focusing on advanced techniques and patient-centered care, Dr. Benjamin Stong and his team at Kalos Hair Transplant continue to set the standard for excellence in hair restoration.
“Through our agreement with DTRA, our broad-spectrum antiviral research program will address the DoD’s goal of protecting U.S. Joint Forces in the event biological weapons are introduced onto the battlefield,” said Seth Lederman, M.D., President, and Chief Executive Officer of Tonix. “The DoD announced in December 2022 that they are moving beyond a ‘one bug, one drug’ approach and are seeking broad-spectrum drugs since one cannot predict which or how many viruses may be deployed.1 This funding provides important validation for our ongoing research and current in-house capabilities, and will enable Tonix to advance its antiviral discovery program.”
The $34 million five-year contract will help fund and accelerate the development of the Company’s broad-spectrum antiviral program, which has the potential to reduce viral load and allow the adaptive immune system to alert the other arms of the immune system to mount a protective response. Tonix plans to leverage previous research on phosphatase inhibitors, specifically compounds that target CD45, to optimize lead compounds for therapeutic intervention of biothreat agents and provide the government with a complete and cost-effective solution for a broad-spectrum medical countermeasure. Tonix’s premise is that partial inhibition of CD45 will provide optimal antiviral protection while requiring lower plasma drug concentrations, a lower dose, and a better safety profile.
Tonix will utilize its state-of-the-art research laboratory capabilities, including a Biosafety Level 3 (BSL-3) lab and an Animal Biosafety Level 3 (ABSL-3) facility at its research and development center (RDC) located in Frederick, Md., as well as experienced personnel in-house. The RDC is located in Maryland’s ‘I-270 biotech corridor’ and is close to the center of the U.S. biodefense research community.
The Defense Threat Reduction Agency (DTRA), an agency within the United States Department of Defense (DoD) is both a Defense Agency and Combat Support Agency with two distinct yet highly integrated roles countering Weapons of Mass Destruction (WMD) and emerging threats. Its origins stretch back to World War II and the Manhattan Project, but today the agency encompasses a wide variety of strategic and operational functions that deter, prevent, and ultimately prevail against these unique threats. DTRA enables the Department of Defense (DoD), the United States Government and international partners to counter and deter weapons of mass destruction (WMD) and emerging threats. DTRA provides cross-cutting solutions to enable the Department of Defense, the United States Government, and international partners to deter strategic attack against the United States and its allies; prevent, reduce, and counter WMD and emerging threats; and prevail against WMD-armed adversaries in crisis and conflict. DTRA’s continued effort to enhance the combat support mission also advances public health services by developing innovative technologies that protect against biological threats. For more information, visit http://www.dtra.mil.
Tonix Pharmaceuticals Holding Corp.*
Tonix is a fully-integrated biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix’s development portfolio is focused on central nervous system (CNS) disorders. Tonix’s priority is to submit a New Drug Application (NDA) to the FDA in the second half of 2024 for Tonmya1, a product candidate for which two statistically significant Phase 3 studies have been completed for the management of fibromyalgia. TNX-102 SL is also being developed to treat acute stress reaction as well as fibromyalgia-type Long COVID. Tonix’s CNS portfolio includes TNX-1300 (cocaine esterase), a biologic designed to treat cocaine intoxication that has Breakthrough Therapy designation. Tonix’s immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease. Tonix Medicines, our commercial subsidiary, markets Zembrace® SymTouch® (sumatriptan injection) 3 mg and Tosymra® (sumatriptan nasal spray) 10 mg for the treatment of acute migraine with or without aura in adults.
*Tonix’s product development candidates are investigational new drugs or biologics and have not been approved for any indication.
1Tonmya™ is conditionally accepted by the U.S. Food and Drug Administration (FDA) as the tradename for TNX-102 SL for the management of fibromyalgia. Tonmya has not been approved for any indication.
Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. All other marks are property of their respective owners.
“This is an amazing program that we are excited to share with the Native community,” said Ray Southworth, Board Chair of NAJS. “Through our partnership with Health Tech Academy, we hope to provide young Native people with the opportunity to gain career-oriented skills so they can support their local communities.”
Karla Coleman, National Director of Workforce Development for Health Tech Academy, expressed her enthusiasm: “I am thrilled about this partnership with NAJS. Together, we are not only addressing critical Allied healthcare staffing needs but also empowering Native American individuals with valuable skills and career opportunities. This collaboration is a significant step towards fostering growth, education, and success within Native communities.”
About Health Tech Academy
Headquartered in Austin, Texas, Health Tech Academy aims to transform healthcare education and staffing. With a focus on excellence, innovation, and personalized learning, our flexible healthcare bootcamps are delivered 100% online, self-paced, and tailored to fit seamlessly into your schedule. We collaborate with universities and employers to transform the healthcare workforce, one talent at a time.
Native American Jump Start is a Jackson, WY based 501 (c)(3) nonprofit organization whose mission is to provide opportunities of growth and success for Native American individuals and families through education and employment. In addition to providing support to Native peoples, they also co-host the Annual Teton Powwow in May of each year.
“We are thrilled to partner with SAGECare in our shared mission to improve the lives of LGBTQ+ older adults,” said April Kohnen, Director of Home Care Services. “At Griswold, we believe in fostering a community where everyone feels respected, valued, and celebrated for who they are. As the only home care provider in San Diego to hold this credential, it reaffirms our dedication to providing an inclusive environment that prioritizes the well-being of all in need of a professional caregiver.”
The SAGECare credential process evaluates senior care providers based on various criteria, including non-discrimination policies, staff training on LGBTQ+ cultural competency, community engagement, and resident support services. By meeting and exceeding these standards, Griswold Home Care for North San Diego has demonstrated its commitment to promoting a diverse and supportive environment for LGBTQ+ seniors.
For more information about SAGECare Training, visit here.
About Griswold Home Care for North San Diego:
Griswold Home Care for North San Diego is a provider of exceptional home care services, dedicated to helping older adults and individuals with disabilities live independently and comfortably in their own homes. They are committed to delivering compassionate, personalized care that respects the dignity and individuality of each client. Specializing in dementia care, Griswold Home Care employs home care aides who are trained to support clients with diminished cognitive abilities, ensuring they receive the best possible care tailored to their unique needs. Follow on Facebook and LinkedIn.
About SAGECare:
SAGECare is a fee-for-service training and consulting division of SAGE (1978), the nation’s oldest and largest non-profit that advocates and provides services for LGBTQ+ senior adults. SAGECare provides LGBTQ+ competency training and consulting to service providers, fostering a more inclusive and understanding approach to aging issues within the LGBTQ+ community.
Media Contact
April Kohnen, Griswold Home Care for North San Diego, 1 (858) 240-2282, [email protected], griswoldhomecare.com/north-san-diego
LGBTQIA+ individuals often experience higher rates of mental health disorders such as depression, anxiety, and suicidal ideation, as well as substance use issues linked to stress and discrimination. These challenges necessitate specialized care tailored to their unique experiences.
Program Benefits and Importance
The LGBTQIA+ Addiction Treatment Program integrates traditional practices like Cognitive Behavioral Therapy (CBT) with innovative holistic therapies. It also offers specialized services such as trauma-informed care and support for co-occurring mental health conditions. These tailored approaches ensure effective outcomes for clients, addressing the unique stressors and discrimination that LGBTQIA+ individuals often face.
Impact on the Las Vegas Community
This program is a significant addition to the Las Vegas community, offering essential support to a population that experiences higher rates of mental health and substance use issues. By providing a safe and affirming space, Virtue Recovery Las Vegas aims to enhance the well-being and quality of life for LGBTQIA+ individuals. The program also contributes to the broader community by promoting acceptance, understanding, and reducing stigma.
Engaging Local Media and Residents
Virtue Recovery Las Vegas invites local media and residents to learn more about this groundbreaking program and its benefits. Community engagement and awareness are crucial in creating a supportive environment for recovery.
Creating Supportive Environments
The program emphasizes the importance of family and community support, providing a safe and affirming space for individuals to heal. Professional support from LGBTQIA+-friendly therapists and healthcare providers is also key to ensuring culturally competent and inclusive care.
“At Virtue Recovery Center, creating a supportive environment isn’t just a goal—it’s our mission. We know that a welcoming and inclusive space is essential for true healing. We’re here to ensure every individual feels seen, valued, and celebrated for who they are.” – Adam Parker, Program Manager LGBTQIA+
Tailored Treatment Programs
Virtue Recovery Center offers individualized treatment plans that include Cognitive Behavioral Therapy (CBT), Dialectical Behavior Therapy (DBT), trauma-informed care, and support for co-occurring mental health conditions. The goal is to improve well-being and foster long-term recovery for local community residents.
“Recovery is deeply personal, and our programs are designed to honor that. We craft each treatment plan with a trauma-informed approach to address the unique experiences of LGBTQIA+ individuals, providing a safe space to navigate their journey and embrace their authentic selves.” – Adam Parker, Program Manager LGBTQIA+
Resources and How to Seek Help
Virtue Recovery Center provides numerous resources for LGBTQIA+ individuals facing mental health and substance use challenges. Local support organizations, national helplines, and online resources offer immediate assistance and guidance. Seeking help early is crucial to preventing escalation and improving outcomes.
Virtue Recovery Las Vegas offers a comprehensive range of treatment modalities, including inpatient and outpatient programs, detoxification processes, and various therapeutic approaches. Our methodology integrates traditional practices like Cognitive Behavioral Therapy (CBT) with innovative holistic therapies to ensure effective outcomes for our clients, including those from the LGBTQIA+ community. Located in the vibrant city of Las Vegas, Virtue Recovery Las Vegas collaborates with numerous insurance providers, such as Behavioral Health Options (BHO) and Health Plan of Nevada (HPN). Our commitment to accessibility drives us to continuously establish new partnerships, broadening the reach of our top-tier rehabilitation services to more individuals, particularly LGBTQIA+ individuals seeking recovery.
“We are thrilled to welcome Kristen to this new position on the CVL team,” said David Konur, CEO of CVL. “Her track record of success and established network within the healthcare industry make her an ideal fit for our organization. I look forward to working with her to lead our ASC and OBL staff across the country, as they provide the highest quality cardiovascular care available.”
“I am honored to join CVL and contribute to the continued growth and success of the platform,” Richards said. “I look forward to leveraging my healthcare experience and relationships to lead CVL’s ASCs and OBLs, collaborate with hospitals, and explore opportunities to improve efficiency and streamline care delivery.”
Richards holds a bachelor’s degree in respiratory therapy from Northern Arizona University and an MBA in healthcare administration from Grand Canyon University.
About Cardiovascular Logistics
Cardiovascular Logistics is the comprehensive national platform that enables premier cardiovascular practices to scale and thrive in a dynamic market. The company brings together leading partners who are practicing at the top of their specialty and share a vision for transforming cardiovascular care delivery. Through its deep experience in cardiovascular medicine and practice development, comprehensive resources, and physician-led approach, Cardiovascular Logistics enables top-tier practices to grow in a collaborative environment that’s firmly focused on advancing cardiovascular medicine and improving patient care. To learn more, visit www.CVLhealth.com.
Media Contact: Debra Andrews Marketri for Cardiovascular Logistics Email: [email protected] Phone: 215.534.5085
